Medicare Enrolled
Dr. Matthew Uhlman, M.D.
Urology Physician · Yakima, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Uhlman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Uhlman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Uhlman
Dr. Matthew Uhlman is an urology physician in Yakima, WA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Uhlman performed 29,935 Medicare services across 2,099 unique beneficiaries.
Between the years covered by Open Payments, Dr. Uhlman received a total of $15,660 from 52 pharmaceutical and/or device companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Uhlman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 1% volume in WA
$15,660 industry payments
Medicare Practice Summary
Medicare Utilization ↗29,935
Medicare services
Top 1% in WA for urology physician
2,099
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,871 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
25,500 | $0 | $0 |
| High osmolar contrast material, up to 149 mg/ml iodine A contrast agent containing iodine used to enhance imaging studies. The concentration is up to 149 mg/ml. |
1,610 | $0 | $0 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
721 | $4 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $86 | $199 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $62 | $136 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
219 | $8 | $67 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
170 | $54 | $427 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
148 | $41 | $81 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 133 | $137 | $189 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
102 | $10 | $45 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
74 | $83 | $363 |
| X-ray of body plane An X-ray imaging test that captures a specific plane or section of the body to visualize internal structures. |
67 | $65 | $280 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
62 | $47 | $306 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
49 | $56 | $275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $103 | $287 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
38 | $123 | $600 |
| Simple change of bladder tube | 28 | $71 | $332 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $27 | $100 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
19 | $116 | $747 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
14 | $72 | $302 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $90 | $822 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $103 | $395 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
14 | $26 | $304 |
| Radiologist review of urinary bladder image A radiologist examines and interprets images of the urinary bladder to assess its structure and function. |
13 | $34 | $176 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
12 | $264 | $2,702 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
12 | $948 | $6,463 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $571 | $3,108 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
86.7% medium
13.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,660
Total received (2018-2024)
Avg $2,237/year across 7 years
Top 8% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
259
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,584 (80.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,076 (19.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$820
2023
$1,898
2022
$1,227
2021
$668
2020
$516
2019
$7,528
2018
$3,002
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$111
ACCORD HEALTHCARE, INC.
$83
Astellas Pharma US Inc
$75
COLOPLAST CORP
$71
Ferring Pharmaceuticals Inc.
$70
INTUITIVE SURGICAL, INC.
$68
C. R. Bard, Inc. & Subsidiaries
$47
Axonics, Inc.
$45
ABBVIE INC.
$44
UROGEN PHARMA, INC.
$37
Tolmar, Inc.
$31
PROGENICS PHARMACEUTICALS, INC.
$30
Tempus AI, Inc
$26
Endo USA, Inc.
$26
Sumitomo Pharma America, Inc.
$23
PFIZER INC.
$19
Photocure Inc
$14
Top 3 companies account for 32.8% of 2024 payments
All-time payments by company (2018-2024) ›
Butterfly Network, Inc.
$4,418
Intuitive Surgical, Inc.
$2,616
Coloplast Corp
$2,349
Astellas Pharma US Inc
$1,633
PROCEPT BioRobotics Corporation
$1,006
PFIZER INC.
$478
Janssen Biotech, Inc.
$472
AbbVie, Inc.
$196
180 Medical, Inc.
$132
Endo Pharmaceuticals Inc.
$126
Northgate Technologies, Inc.
$114
Myriad Genetic Laboratories, Inc.
$105
Ferring Pharmaceuticals Inc.
$95
Myovant Sciences Inc.
$93
Dendreon Pharmaceuticals LLC
$92
COLOPLAST CORP
$92
Boston Scientific Corporation
$90
Axonics, Inc.
$89
ACCORD HEALTHCARE, INC.
$83
AbbVie Inc.
$76
Rochester Medical Corporation
$73
Medtronic USA, Inc.
$70
INTUITIVE SURGICAL, INC.
$68
Tolmar, Inc.
$68
TOLMAR Pharmaceuticals, Inc.
$66
Sumitomo Pharma America, Inc.
$65
ABBVIE INC.
$63
Teleflex LLC
$62
Allergan Inc.
$62
Antares Pharma, Inc.
$59
UROVANT SCIENCES INC
$53
ConvaTec Inc.
$51
C. R. BARD, INC. & SUBSIDIARIES
$49
Bayer HealthCare Pharmaceuticals Inc.
$48
C. R. Bard, Inc. & Subsidiaries
$47
Progenics Pharmaceuticals, Inc.
$47
UROGEN PHARMA, INC.
$37
Photocure Inc
$34
Travere Therapeutics, Inc.
$30
PROGENICS PHARMACEUTICALS, INC.
$30
UroGen Pharma, Inc.
$27
Tempus AI, Inc
$26
Endo USA, Inc.
$26
Medtronic, Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$19
Ambu Inc.
$18
Merck Sharp & Dohme LLC
$17
Laborie Medical Technologies Corp.
$17
Hollister Incorporated
$16
Alnylam Pharmaceuticals Inc.
$14
Avadel Specialty Pharmaceuticals, LLC
$11
Amniox Medical, Inc.
$8
Top 3 companies account for 59.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Axonics · BOTOX · BOTOX THERAPEUTIC · Bulkamid · Butterfly iQ · CAMCEVI · CYSVIEW · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL MALE SUI · GENTLECATH · GentleCath · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OXLUMO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SPEEDICATH · SpaceOAR VUE System - 10mL · TITAN · TOVIAZ · Thiola · Titan · UROLIFT · VaPro Pocket · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for urology physician in WA.
Geographic Context
Urology physicians within 10 mi
9
Per 100K population
3.5
County median income
$68,015
Nearest hospital
YAKIMA VALLEY MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Uhlman is a mixed practice specialist, with above-average Medicare volume (top 1% in WA), with low-engagement industry engagement in the top 8% of WA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Uhlman experienced with testosterone injection?
Based on Medicare claims data, Dr. Uhlman performed 25,500 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Uhlman receive payments from pharmaceutical companies?
Yes. Dr. Uhlman received a total of $15,660 from 52 companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Uhlman's costs compare to other urology physicians in Yakima?
Dr. Uhlman's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Uhlman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Yakima
Browse urology physicians in Yakima ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
Butterfly Network, Inc. Payments to Doctors
See all physicians who received payments from Butterfly Network, Inc.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology